Comprehensive coverage

compugen

Compugen company employees on the eve of the offering

Immune Control Protein Discovered by Compugen Shows Potential for Developing New Cancer Immunotherapy Drugs

  • No comments
Small cell lung cancer, from Wikipedia

Biotechnology - group of announcements: Compugen, Glamed and Itamar Medical, Algatech

  • One response
An energy transfer system for an artificial heart by Leviticos. PR photo

Biotechnology cluster: Levitas Cardio recruits; And also on: Protlix, Yes Fit, Redhill Biopharma, Compugen and a joint venture with Germany in the field of biotechnology

  • No comments
Biotechnology. Illustration: shutterstock

Biotechnology Cluster: New Incubator Company; European marketing agreement for Silantis seal; Cooperative Compugen-Bayer

  • No comments
Dr. Anat Cohen-Dig, CEO of Compugen

Compugen and Mark Sarono's venture capital fund are jointly establishing Neviah Genomics) a new company for the discovery and development of diagnostic markers

  • No comments
pills. From Wikipedia

Compugen expands and accelerates the program to develop antibodies to treat cancer and diseases of the immune system

  • No comments

The hunger for knowledge

  • One response

Compugen Announces New Platform for Identifying Viral Peptides for Drug Use Against Human Inflammatory Diseases

  • No comments

Compugen announces the discovery of a new medicinal peptide candidate for the treatment of solid cancerous tumors

  • No comments

Compugen announces discovery of markers for early detection of kidney damage caused by drugs in preclinical development stages

  • No comments

Compugen Announces Discovery of New Targets for Drug Antibodies for Cancer

  • No comments

Compugen reports finding a marker to detect the destruction of heart tissue

  • No comments

Compugen announces a new platform for the discovery of peptides that block protein structures associated with diseases

  • 2 תגובות

Compugen announces an agreement with Teva covering a protein variant of MCP1 for the treatment of chronic inflammatory diseases

  • One response

Clal Biotechnology Industries has announced that it has completed the acquisition of DiaPep277 rights from Davlogan

  • No comments

Compugen to Collaborate with Mayo Clinic to Discover New Diagnostic Markers for Unstable Atherosclerotic Plaque

  • No comments

Compugen: cooperation for the development of diagnostic products with Johnson & Johnson

  • No comments

Compugen and Novartis will collaborate on research in the field of systems biology

  • No comments
tomato. Source: Wikimedia / Manjithkaini.

Ivogen and Compugen will test the production of human proteins in wild tomatoes

  • No comments

Compugen announces a scientific breakthrough: a fifth nucleic acid in RNA is more common than known

  • No comments

Compugen establishes Kedem Biosciences, a subsidiary for the discovery of small molecules for pharmaceutical purposes

  • No comments

Compugen and Tel Aviv University discovered a unique prediction method

  • No comments

Compugen enters the DNA chip production market; Celera offered the Israeli government to buy the use of

  • No comments

Who owns the rights to the human genome?

  • No comments

The book is already here, you just have to learn to read - an interview with one of the heads of the human genome project

  • No comments
Science website logo
SEARCH